Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species

Stroke

Volumn 40, Issue 4, 2009, Pages 1091-1097

  De Silva, T Michael ^a   Biomed, B ^a   Broughton, Brad R S ^a   Drummond, Grant R ^a   Sobey, Christopher G ^a   Miller, Alyson A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; Cerebral arteries; Gender; NAD(P)H oxidase; Reactive oxygen species

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; AMINE OXIDE; ANTIOXIDANT; CYBB PROTEIN, MOUSE; EUK-134; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MEMBRANE PROTEIN; NOS3 PROTEIN, MOUSE; ORGANOMETALLIC COMPOUND; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SALICYLIC ACID DERIVATIVE; TEMPOL; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; ENDOTHELIUM CELL; FEMALE; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEX DIFFERENCE; ANIMAL; BRAIN ARTERY; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SEXUAL DEVELOPMENT; SPIN LABELING; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; CEREBRAL ARTERIES; CYCLIC N-OXIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; ORGANOMETALLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SALICYLATES; SEX CHARACTERISTICS; SPIN LABELS; SUPEROXIDE DISMUTASE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 65249161087     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.531707     Document Type: Article

References (20)

1. van Dijk EJ, Breteler MMB, Schmidt R, Berger K, Nilsson L-G, Oudkerk M, Pajak A, Sans S, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A, for the CC. The association between blood pressure, hypertension, and cerebral white matter lesions: Cardiovascular determinants of dementia study. Hypertension. 2004;44:625-630.
2. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension. 2003;41:50-55.
3. Ando H, Zhou J, Macova M, Imboden H, Saavedra JM. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke. 2004;35:1726-1731.
4. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res. 2004;95:1019-1026.
5. Miller A, Drummond G, Schmidt H, Sobey C. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005;97:1055-1062.
6. Miller AA, Drummond GR, Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacology & Therapeutics. 2006;111:928-948.
7. Kazama K, Wang G, Frys K, Anrather J, Iadecola C. Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. Am J Physiol Heart Circ Physiol. 2003;285:H1890-H1899.
8. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcircu-lation through Nox-2-derived radicals. Arterioscler Thromb Vasc Biol. 2006;26:826-832.
9. Prencipe M, Ferretti C, Casini A, Santini M, Giubilei F, Culasso F. Stroke, disability and dementia: Results of a population study. Stroke. 1997;28:531-536.
10. Miller AA, De Silva TM, Jackman KA, Sobey CG. Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol. 2007;34:1037-1043.
11. Miller AA, Drummond GR, Mast AE, Schmidt HHHW, Sobey CG. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: Role of estrogen. Stroke. 2007;38:2142-2149.
12. Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP. Cerebral vascular effects of angiotensin II: New insights from genetic models. J Cereb Blood Flow Metab. 2005;26:449-455.
13. Girouard H, Lessard A, Capone C, Milner TA, Iadecola C. The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic. Am J Physiol Heart Circ Physiol. 2008;294: H156-H163.
14. Paravicini TM, Gulluyan LM, Dusting GJ, Drummond GR. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ Res. 2002;91:54-61.
15. Haberl RL, Anneser F, Villringer A, Einhaupl KM. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am J Physiol Heart Circ Physiol. 1990;258:H1840-H1846.
16. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res. 2005;96:818-822.
17. Toda N, Ayaziki K, Okamura T. Modifications by endogenous prosta-glandins of angiotensin II-induced contractions in dog and monkey cerebral and mesenteric arteries. J Pharmacol Exp Ther. 1990;252: 374-379.
18. Whalley ET, Paul KS, Gulati OP. Anti-spasmogenic effects of bencianol (zyl5051) on human cerebral arteries in vitro. Cephalalgia. 1985;5: 217-221.
19. Vincent J-M, Kwan YW, Lung Chan S, Perrin-Sarrado C, Atkinson J, Chillon J.-M. Constrictor and dilator effects of angiotensin II on cerebral arterioles. Stroke. 2005;36:2691-2695.
20. Haberl RL, Decker PJ, Einhaupl KM. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res. 1991;68:1621-1627.